… The interaction of adaptive and innate immune cells in the pannus contributes not only to
an overwhelming release of cytokines but also to local secretion of pro-inflammatory alarmins. …

… Moreover, the role of various cytokines and chemokines in atherosclerosis is discussed in-depth
elsewhere [Citation27]. Briefly, cytokine IL-8 expressed by activated/dysfunctional ECs …

… of interleukin 17A (IL-17A), also known as effector cytokine of Th17 cells, is distinguished,
which is currently recognized as one of the most promising therapeutic targets [16]. …

… on the scene of atherosclerosis and their interaction is … molecules thereby promoting
atherosclerosis. Inflammation is … may facilitate the genesis of atherosclerosis, independently of its …

… , atherosclerosis, and heart failure (HF). ILs have emerged as promising therapeutic targets
for … IL-17A is another inflammation-promoting cytokine linked to atherosclerosis and CVD …

… A-FABP expression in adipose tissue are causally associated with obesity-related inflammation
and vascular dysfunction, both adipokines represent promising therapeutic targets for …

… with a chronic inflammatory response mediated by a range of cytokines [4,5]. The lipid-rich …
in the pathogenesis of atherosclerosis are all promising therapeutic targets, major success …

… We then discuss the interactions among macrophages, cytokines, and vascular adventitial …
and oestrogen receptors are regarded as promising therapeutic targets in PH [50]. Additionally…

… Cytokines in atherosclerosis: Key players in all stages of disease and promising
therapeutic targets. Cytokine Growth Factor Rev 2015: S1359-6101(15):32-5. …

… exploitation as promising therapeutic targets to treat CAVD and reduce valve replacement. …
pro-inflammatory cytokines among which IL-6 and TNF-α. Proinflammatory cytokines impairs …